Skip to content

Author

Han-Wen Zheng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Sep 2026

Incremental effects of SGLT2 inhibitors, GLP-1 receptor agonists, and pioglitazone in type 2 diabetes and MASLD across Asian study settings: a systematic review and meta-analysis

Objective We evaluated the incremental hepatic and metabolic effects of adding sodium–glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs), or pioglitazone to comparable background glucose-lowering therapy in Asian adults with type 2 diabetes mellitus (T2DM) and metabolic dys...

Han-Wen Zheng, Jie-Ru Han · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.